Over 200 new sequences are generated for members of the genus
Acremonium and related taxa including ribosomal small subunit
sequences (SSU) for phylogenetic analysis and large subunit (LSU) sequences
for phylogeny and DNA-based identification. Phylogenetic analysis reveals that
within the Hypocreales, there are two major clusters containing
multiple Acremonium species. One clade contains Acremonium
sclerotigenum, the genus Emericellopsis, and the genus
Geosmithia as prominent elements. The second clade contains the
genera Gliomastix sensu stricto and Bionectria. In
addition, there are numerous smaller clades plus two multi-species clades, one
containing Acremonium strictum and the type species of the genus
Sarocladium, and, as seen in the combined SSU/LSU analysis, one
associated subclade containing Acremonium breve and related species
plus Acremonium curvulum and related species. This sequence
information allows the revision of three genera. Gliomastix is
revived for five species, G. murorum, G. polychroma, G. tumulicola, G.
roseogrisea, and G. masseei. Sarocladium is extended to
include all members of the phylogenetically distinct A. strictum
clade including the medically important A. kiliense and the
protective maize endophyte A. zeae. Also included in
Sarocladium are members of the phylogenetically delimited
Acremonium bacillisporum clade, closely linked to the A.
strictum clade. The genus Trichothecium is revised following the
principles of unitary nomenclature based on the oldest valid anamorph or
teleomorph name, and new combinations are made in Trichothecium for
the tightly interrelated Acremonium crotocinigenum, Spicellum
roseum, and teleomorph Leucosphaerina indica. Outside
the Hypocreales, numerous Acremonium-like species fall into
the Plectosphaerellaceae, and A. atrogriseum falls into the
Cephalothecaceae.
Transmission tests were conducted with field-collected Bunchy Top Symptoms (BTS) phytoplasma-infected specimens of Empoasca papayae. BTS developed in all eight inoculated papayas 3 months later. The BTS phytoplasma was identified in six of eight inoculated papayas, whose partial 16S rRNA sequence (GenBank Accession no. FJ6492000) was 99.9% identical with those from the collected papayas (GenBank Accession no FJ649198) and E. papayae (GenBank Accession no. FJ649199), all of which are members of group 16SrII, ÔCandidatus Phytoplasma aurantifoliaÕ. Results confirmed the ability of E. papayae to transmit the BTS phytoplasma.
Surveys for the Côte d'Ivoire lethal yellowing (CILY) phytoplasma were conducted in eight severely CILY-affected villages of Grand-Lahou in 2015. Leaves, inflorescences and trunk borings were collected from coconut palms showing CILY symptoms and from symptomless trees. Total DNA was extracted from these samples and tested by nested polymerase chain reaction/RFLP and sequence analysis of the 16S rRNA, ribosomal protein (rp) and the translocation protein (secA) genes. The CILY phytoplasma was detected in 82.9% of the symptom-bearing palms collected from all the surveyed villages and from all the plant parts. Trunk borings were recommended as the most suitable plant tissue type for sampling. Results indicate that the CILY phytoplasma may have a westward spread to other coconut-growing areas of Grand-Lahou. CILY phytoplasma strains infecting coconut palms in the western region of Grand-Lahou exhibited unique single nucleotide polymorphisms on the rp sequence compared to the strains from the eastern region. Moreover, single nucleotide polymorphisms on the SecA sequence distinguished the CILY phytoplasma from the Cape St. Paul Wilt Disease phytoplasma in Ghana, and the Lethal Yellowing phytoplasma in Mozambique. (Résumé d'auteur
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.